Clinical Trial Update: A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SI-B003 and the BL-B01D1+SI-B003 combination in locally advanced or metastatic non-small cell lung cancer, nasopharyngeal carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• BL-B01D1
• SI-B003

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma | Phase 2 | Status: RECRUITING